Mirum Pharmaceuticals, Inc. is a clinical-stage therapeutics company developing a novel approach for treating cholestatic liver diseases, with an immediate focus on rare pediatric conditions.
- Year invested 2018
- Investment Stage Early
- Board Members
- Sectors
- Investment Status Current
- Website mirumpharma.com/
- Company Status IPO/Public (NASDAQ: MIRM)